We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Comment on Umapathysivam et al. Euglycemic Ketoacidosis in Two Patients Without Diabetes After Introduction of Sodium–Glucose Cotransporter 2 Inhibitor for Heart Failure With Reduced Ejection Fraction. Diabetes Care 2024;47:140–143.
- Authors
Nakasone, Yasuto; Yamashita, Koh; Aizawa, Toru
- Abstract
The article focuses on commenting on a case report by Umapathysivam et al. regarding euglycemic ketoacidosis in two non-diabetic patients treated with sodium glucose cotransporter 2 inhibitors (SGLT2i) for heart failure with reduced ejection fraction. It reports concerns about the possible role of glucocorticoids in contributing to ketoacidosis, emphasizing the need for clinicians to consider comprehensive review of known pathophysiology.
- Subjects
SODIUM-glucose cotransporter 2 inhibitors; HEART failure; KETOACIDOSIS; VENTRICULAR ejection fraction; ALDOSTERONE antagonists; PEOPLE with diabetes; DIABETES; CANAGLIFLOZIN
- Publication
Diabetes Care, 2024, Vol 47, Issue 4, pe34
- ISSN
0149-5992
- Publication type
Article
- DOI
10.2337/dc23-2473